Motilal Oswal BSE Healthcare ETF - Growth - Regular Plan

Other Plans and Options
  • (-0.22%)Nav, as on 25-02-2025

  • Previous Nav

  • Net Change on 25-02-2025

  • PersonalFN Rating

  • Category

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the Constituents of S&P BSE Healthcare Index, subject to tracking error.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI -6.61 -9.15 10.67 19.98 23.65 15.26

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI Nifty 50 ETF Jul 22, 2015 2.68 11.85 15.02 0.04 189,650.42
SBI BSE SENSEX ETF Mar 15, 2013 3.13 11.44 14.42 0.04 110,720.76
UTI Nifty 50 ETF Sep 01, 2015 2.68 11.85 15.03 0.05 57,440.04
UTI BSE Sensex ETF Sep 01, 2015 3.13 11.44 14.41 0.05 43,451.23
Nippon India ETF Nifty 50 BeES Dec 28, 2001 2.69 11.87 15.06 0.04 38,966.12

Fund Holdings as on 31-January-2025

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Max Healthcare Institute Limited

  • Dr. Reddy's Laboratories Limited

  • Divi's Laboratories Limited

  • Apollo Hospitals Enterprise Limited

  • Lupin Limited

  • Fortis Healthcare Limited

  • Aurobindo Pharma Limited

  • Torrent Pharmaceuticals Limited

  • Alkem Laboratories Limited

  • Mankind Pharma Limited

  • Zydus Lifesciences Limited

  • Laurus Labs Limited

  • Glenmark Pharmaceuticals Limited

  • IPCA Laboratories Limited

  • Biocon Limited

  • Krishna Institute Of Medical Sciences Limited

  • Piramal Pharma Limited

  • Syngene International Limited

  • Suven Pharmaceuticals Limited

  • Abbott India Limited

  • Concord Biotech Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Neuland Laboratories Limited

  • Gland Pharma Limited

  • Ajanta Pharma Limited

  • Wockhardt Limited

  • Aster DM Healthcare Limited

  • Dr. Lal Path Labs Limited

  • Natco Pharma Limited

  • Narayana Hrudayalaya Limited

  • Poly Medicure Limited

  • Global Health Limited

  • Granules India Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Jubilant Pharmova Limited

  • Rainbow Childrens Medicare Limited

  • Pfizer Limited

  • Jupiter Life Line Hospitals Limited

  • Ami Organics Limited

  • Eris Lifesciences Limited

  • Alembic Pharmaceuticals Limited

  • Sanofi India Limited

  • Marksans Pharma Limited

  • Vijaya Diagnostic Centre Limited

  • Metropolis Healthcare Limited

  • Strides Pharma Science Limited

  • AstraZeneca Pharma India Limited

  • Procter & Gamble Health Limited

  • Caplin Point Laboratories Limited

  • Shilpa Medicare Limited

  • Alivus Life Sciences Limited

  • Indegene Limited

  • Aarti Pharmalabs Limited

  • Kovai Medical Center and Hospital Limited

  • FDC Limited

  • Morepen Laboratories Limited

  • Orchid Pharma Limited

  • Healthcare Global Enterprises Limited

  • Indraprastha Medical Corporation Limited

  • Sequent Scientific Limited

  • Supriya Lifescience Limited

  • Blue Jet Healthcare Ltd

  • Sun Pharma Advanced Research Company Limited

  • Advanced Enzyme Technologies Limited

  • Innova Captab Limited

  • Krsnaa Diagnostics Limited

  • Solara Active Pharma Sciences Limited

  • Net Receivables / (Payables)

  • Dishman Carbogen Amcis Limited

  • Unichem Laboratories Limited

  • Aarti Drugs Limited

  • Hikal Limited

  • Thyrocare Technologies Limited

  • Gufic Biosciences Limited

  • Yatharth Hospital And Trauma Care Services Limited

  • RPG Life Sciences Limited

  • Bliss GVS Pharma Limited

  • Gujarat Themis Biosyn Limited

  • Indoco Remedies Limited

  • Artemis Medicare Services Limited

  • Syncom Formulations India Limited

  • IOL Chemicals and Pharmaceuticals Limited

  • Suven Life Sciences Limited

  • Sigachi Industries Limited

  • Hester Biosciences Limited

  • Windlas Biotech Limited

  • Lincoln Pharmaceuticals Limited

  • Themis Medicare Limited

  • Vimta Labs Limited

  • Shalby Limited

  • SMS Pharmaceuticals Limited

  • Tarsons Products Limited

  • Novartis India Limited

  • Kopran Limited

  • GPT Healthcare Limited

  • KMC Speciality Hospitals (India) Limited

  • NGL Fine Chem Limited

  • Sastasundar Ventures Limited

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

  • Chemicals

  • Plastic Products

  • Trading

  • Finance - NBFC

View More

Fund Manager

  • Cash

  • Equity

View More

About Motilal Oswal BSE Healthcare ETF

Scheme Analysis

Motilal Oswal BSE Healthcare ETF is a ETFs - Index fund and belongs to Motilal Oswal Mutual Fund. It was launched on 29-Jul-2022 and currently has an AUM of ₹27.99 crore. Motilal Oswal BSE Healthcare ETF is benchmarked against BSE Health Care - TRI as primary index.

The NAV of Motilal Oswal BSE Healthcare ETF ended down ₹-0.09(-0.22%)yesterday to ₹39.7383.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Motilal Oswal BSE Healthcare ETF is managed by Swapnil P Mayekar and Rakesh Shetty.

Fund House Contact

10th Floor, Motilal Oswal Tower, Rahimtullah Sayani Road, Opp Parel ST Bus Depot, Prabhadevi Mumbai - 400025

022 40548002
amc@motilaloswal.com
022-22816161